Search Results

One day I found a book about poisonous plants—essentially explaining which berries you could eat and You need a solid foundation.

He is Chief Scientific Officer and co-founder of InterAx Biotech, where he specializes in the development Aurélien Rizk co-founded Algorizk, a company that created real-time physics simulations for education They found it fascinating to integrate both fields and the potential it holds. They also touched upon the transferability of this approach across different systems, which Yamina found GPCRs: A Focus for New Company Aurelien Rizk and Yamina Berchiche discussed the founding of a company

affordable gatherings that foster collaboration and mentorship across disciplines — connecting scientists, founders

Berchiche is the founder of Dr.

GPCR Affiliate Program Earn by Empowering the GPCR Ecosystem Help us connect scientists, founders, and

Germain, founder of Company Launch Partners, shares how he transitioned from corporate finance to creating controller at CLP, joined the mission after pivoting from a sales career into accounting, where he found

Since the founding of Celtarys in 2021, she has served as the company’s Chief Scientific Officer, leading of Celtarys’ proprietary synthetic technology and is both a co-author of the related patent and a co-founder

In 2021, she co-founded Celtarys and now leads the company’s scientific direction. Yamina Berchiche, Founder and CEO of Dr. GPCR.

international and national competitive, charitable and commercial sources, as well as being academic co-founder

She co-founded Heptares Therapeutics and served as Chief Scientific Officer for twelve years, through lecture on β-adrenergic signaling set a career in motion 07:07 A venture capital visit to the LMB and the founding As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery

international and national competitive, charitable and commercial sources, as well as being academic co-founder

international and national competitive, charitable and commercial sources, as well as being academic co-founder

Pfleger co-founded a biotech company that completed phase 2 clinical trials in focal segmental glomerulosclerosis Pfleger co-founded a publicly listed biotech company that has completed phase 2 clinical trials in focal Council Centre for Personalised Therapeutics Technologies, Chief Scientific Advisor to Dimerix, and co-founder

From chemokine receptors at Rockefeller to founding Dr. Yamina Berchiche is the founder of the Dr. GPCR ecosystem and the host of the Dr. GPCR Podcast. Berchiche found that deep focus on one project was no longer fulfilling. GPCR was founded in March 2020 after a COVID-era redundancy at Generate Biomedicines. The ecosystem's physical origins are inseparable from its founding conviction.

He is also an entrepreneur and founder of biotechnology companies translating GPCR pharmacology into